Protein kinase D signaling in cancer

Research output: Chapter in Book/Report/Conference proceedingChapter

2 Citations (Scopus)

Abstract

Protein Kinase D is a serine/threonine kinase that shows responsiveness to phorbol esters and diacylglycerol and is a direct target for Src family kinases, RhoGTPases and protein kinase C. Thus PKD on first view represents a bona fide oncogene and is currently investigated for its potential as a drug target for multiple cancers. This is supported by the discovery that PKD promotes tumor cell survival in response to damaging stresses such as increases in reactive oxygen species, but also enhances cell proliferation and DNA synthesis in response to activation by growth factor and G-protein-coupled receptors. Based on these findings, the development of PKD inhibitors is progressed within the field. However, accumulating reports also suggest that PKD activation suppresses directed cell migration and invasion, suggesting that PKD expression may be needed for early tumorigenic events, but is downregulated during metastatic progression. This chapter describes the known roles of PKD isoenzymes in all aspects of tumor biology as well as the signaling mechanisms they use, and discusses their potential value as drug targets in cancer.

Original languageEnglish (US)
Title of host publicationCell Signaling & Molecular Targets in Cancer
PublisherSpringer New York
Pages245-271
Number of pages27
Volume9781461407300
ISBN (Print)9781461407300, 146140729X, 9781461407294
DOIs
StatePublished - May 1 2012

Fingerprint

Neoplasms
src-Family Kinases
Protein-Serine-Threonine Kinases
Diglycerides
Phorbol Esters
G-Protein-Coupled Receptors
Oncogenes
Pharmaceutical Preparations
Protein Kinase C
Isoenzymes
Cell Movement
Reactive Oxygen Species
Cell Survival
Intercellular Signaling Peptides and Proteins
Down-Regulation
Cell Proliferation
protein kinase D
DNA

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Storz, P. (2012). Protein kinase D signaling in cancer. In Cell Signaling & Molecular Targets in Cancer (Vol. 9781461407300, pp. 245-271). Springer New York. https://doi.org/10.1007/978-1-4614-0730-0_11

Protein kinase D signaling in cancer. / Storz, Peter.

Cell Signaling & Molecular Targets in Cancer. Vol. 9781461407300 Springer New York, 2012. p. 245-271.

Research output: Chapter in Book/Report/Conference proceedingChapter

Storz, P 2012, Protein kinase D signaling in cancer. in Cell Signaling & Molecular Targets in Cancer. vol. 9781461407300, Springer New York, pp. 245-271. https://doi.org/10.1007/978-1-4614-0730-0_11
Storz P. Protein kinase D signaling in cancer. In Cell Signaling & Molecular Targets in Cancer. Vol. 9781461407300. Springer New York. 2012. p. 245-271 https://doi.org/10.1007/978-1-4614-0730-0_11
Storz, Peter. / Protein kinase D signaling in cancer. Cell Signaling & Molecular Targets in Cancer. Vol. 9781461407300 Springer New York, 2012. pp. 245-271
@inbook{7007a18ec73540009b25577e825538a8,
title = "Protein kinase D signaling in cancer",
abstract = "Protein Kinase D is a serine/threonine kinase that shows responsiveness to phorbol esters and diacylglycerol and is a direct target for Src family kinases, RhoGTPases and protein kinase C. Thus PKD on first view represents a bona fide oncogene and is currently investigated for its potential as a drug target for multiple cancers. This is supported by the discovery that PKD promotes tumor cell survival in response to damaging stresses such as increases in reactive oxygen species, but also enhances cell proliferation and DNA synthesis in response to activation by growth factor and G-protein-coupled receptors. Based on these findings, the development of PKD inhibitors is progressed within the field. However, accumulating reports also suggest that PKD activation suppresses directed cell migration and invasion, suggesting that PKD expression may be needed for early tumorigenic events, but is downregulated during metastatic progression. This chapter describes the known roles of PKD isoenzymes in all aspects of tumor biology as well as the signaling mechanisms they use, and discusses their potential value as drug targets in cancer.",
author = "Peter Storz",
year = "2012",
month = "5",
day = "1",
doi = "10.1007/978-1-4614-0730-0_11",
language = "English (US)",
isbn = "9781461407300",
volume = "9781461407300",
pages = "245--271",
booktitle = "Cell Signaling & Molecular Targets in Cancer",
publisher = "Springer New York",

}

TY - CHAP

T1 - Protein kinase D signaling in cancer

AU - Storz, Peter

PY - 2012/5/1

Y1 - 2012/5/1

N2 - Protein Kinase D is a serine/threonine kinase that shows responsiveness to phorbol esters and diacylglycerol and is a direct target for Src family kinases, RhoGTPases and protein kinase C. Thus PKD on first view represents a bona fide oncogene and is currently investigated for its potential as a drug target for multiple cancers. This is supported by the discovery that PKD promotes tumor cell survival in response to damaging stresses such as increases in reactive oxygen species, but also enhances cell proliferation and DNA synthesis in response to activation by growth factor and G-protein-coupled receptors. Based on these findings, the development of PKD inhibitors is progressed within the field. However, accumulating reports also suggest that PKD activation suppresses directed cell migration and invasion, suggesting that PKD expression may be needed for early tumorigenic events, but is downregulated during metastatic progression. This chapter describes the known roles of PKD isoenzymes in all aspects of tumor biology as well as the signaling mechanisms they use, and discusses their potential value as drug targets in cancer.

AB - Protein Kinase D is a serine/threonine kinase that shows responsiveness to phorbol esters and diacylglycerol and is a direct target for Src family kinases, RhoGTPases and protein kinase C. Thus PKD on first view represents a bona fide oncogene and is currently investigated for its potential as a drug target for multiple cancers. This is supported by the discovery that PKD promotes tumor cell survival in response to damaging stresses such as increases in reactive oxygen species, but also enhances cell proliferation and DNA synthesis in response to activation by growth factor and G-protein-coupled receptors. Based on these findings, the development of PKD inhibitors is progressed within the field. However, accumulating reports also suggest that PKD activation suppresses directed cell migration and invasion, suggesting that PKD expression may be needed for early tumorigenic events, but is downregulated during metastatic progression. This chapter describes the known roles of PKD isoenzymes in all aspects of tumor biology as well as the signaling mechanisms they use, and discusses their potential value as drug targets in cancer.

UR - http://www.scopus.com/inward/record.url?scp=84938985982&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84938985982&partnerID=8YFLogxK

U2 - 10.1007/978-1-4614-0730-0_11

DO - 10.1007/978-1-4614-0730-0_11

M3 - Chapter

SN - 9781461407300

SN - 146140729X

SN - 9781461407294

VL - 9781461407300

SP - 245

EP - 271

BT - Cell Signaling & Molecular Targets in Cancer

PB - Springer New York

ER -